A Study of the Efficacy and Safety of Apremilast (CC-10004) in Subjects With Moderate to Severe Plaque Psoriasis of the Scalp
Clinical trial NCT03123471 · COMPLETED
Trial details
- NCT number
- NCT03123471
- Sponsor
- Amgen
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-05-16
- Primary completion
- 2018-08-13
- Enrollment
- 303
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.